ankylosing spondylitis

Search with Google Search with Bing
Information
Disease name
ankylosing spondylitis
Disease ID
DOID:7147
Description
"A bone inflammation disease that results_in inflammation in the joints of the spine and pelvis. The disease has_symptom pain, has_symptom stiffness in the spine, has_symptom stiffness in the neck, has_symptom stiffness in the hips, has_symptom stiffness in the jaw and has_symptom stiffness in the rib cage." [url:http\://en.wikipedia.org/wiki/Ankylosing_spondylitis, url:http\://www.mayoclinic.com/health/ankylosing-spondylitis/DS00483, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000420.htm, url:http\://www.spondylitis.org/about/as.aspx] {comment="ls:IEDB"}
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04809168 Active, not recruiting Neuropathic Spinal Pain in Ankylosing Spondylitis April 6, 2021 November 2, 2024
NCT02469753 Active, not recruiting Phase 3 Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes October 23, 2015 June 2024
NCT05527444 Active, not recruiting Phase 4 The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients March 15, 2022 December 31, 2024
NCT05862584 Active, not recruiting N/A Impact of Air Pollution on the Course of Inflammatory Rheumatism May 26, 2023 July 30, 2024
NCT05155098 Active, not recruiting 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis March 25, 2022 February 28, 2025
NCT02281747 Active, not recruiting Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries October 24, 2014 May 31, 2029
NCT03447704 Active, not recruiting Phase 3 International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis February 9, 2018 April 5, 2023
NCT04436640 Active, not recruiting Phase 3 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis June 16, 2020 August 7, 2026
NCT00133315 Completed Phase 4 TNFalfa Blocking Treatment of Spondylarthropathies September 2004 April 2007
NCT00195416 Completed Study Investigating Enbrel Treatment for Ankylosing Spondylitis June 2005 August 2008
NCT00195819 Completed Phase 3 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis December 2003 June 2009
NCT00207701 Completed Phase 3 A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. September 2002 February 2005
NCT00000416 Completed N/A Prevention of Arthritis-Related Work Disability September 1997 August 2001
NCT00227227 Completed Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis May 2004 June 2007
NCT06226792 Completed Muscle Architecture in Ankylosing Spondylitis January 18, 2024 March 2, 2024
NCT06185712 Completed N/A Patient Education in Ankylosing Spondylitis August 1, 2020 June 30, 2021
NCT00247962 Completed Phase 4 Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis December 2005 February 2008
NCT06094686 Completed Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis August 1, 2015 January 2, 2016
NCT00356356 Completed Phase 3 16.0040 Ankylosing Spondylitis Study April 2002 September 2006
NCT00367211 Completed Phase 3 Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. September 2006 September 2007
NCT00383617 Completed Referral Recommendations for Axial Spondyloarthritis July 2004
NCT00410046 Completed Phase 4 Extension Study Evaluating Etanercept in Ankylosing Spondylitis December 2006 October 2008
NCT00418548 Completed Phase 3 Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis June 2004 February 2005
NCT00420238 Completed Phase 4 Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis January 2007 May 2009
NCT00421915 Completed Phase 3 Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis March 2002 August 2002
NCT00421980 Completed Phase 3 An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis June 2002 July 2004
NCT00432432 Completed Phase 4 Combination Methotrexate and Infliximab February 2005 October 2006
NCT06094673 Completed The Relationship Between Systemic Immune Inflammation Index and Disease Activity in Patients With Ankylosing Spondylitis June 1, 2023 July 2, 2023
NCT00434044 Completed Phase 3 Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis February 2007 June 2007
NCT00439283 Completed Phase 3 Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis April 2003 December 2004
NCT00444340 Completed Phase 4 An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis April 2004 July 2007
NCT00458185 Completed Phase 4 Study Evaluating Etanercept in Patients With Ankylosing Spondylitis August 2006 April 2007
NCT00478660 Completed Phase 3 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) February 2006
NCT00507403 Completed Phase 4 Infliximab and Methotrexate in Ankylosing Spondylitis October 2007 December 2009
NCT06085534 Completed Phase 2 A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis January 6, 2022 June 20, 2023
NCT00544557 Completed Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis October 2007 May 2014
NCT05987111 Completed N/A Pilates in Ankylosing Spondylitis August 2, 2022 February 10, 2023
NCT00576706 Completed Phase 3 PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity December 2007 March 2010
NCT00643526 Completed Early Phase 1 A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector December 2007 January 2008
NCT00647517 Completed Phase 4 Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis March 2008 July 2009
NCT00667355 Completed Phase 3 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis February 2008 January 2011
NCT00715091 Completed Phase 4 Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis September 2008 December 2013
NCT00722514 Completed N/A Evaluation of a Patient Education Program for Ankylosing Spondylitis July 1998 July 2001
NCT00724529 Completed Post Marketing Surveillance of Remicade June 2007 August 2011
NCT00751387 Completed Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia November 2008 September 2009
NCT00762463 Completed Phase 3 Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis July 2009 August 2010
NCT00809159 Completed Phase 2 Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis March 2009 May 2011
NCT00844805 Completed Phase 3 Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) September 2009 September 2011
NCT00858819 Completed Clinical Trial of Osteoporosis in Ankylosing Spondylitis March 2009 December 2014
NCT00873730 Completed Phase 4 Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain December 2006 June 2008
NCT00900796 Completed Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis March 2009 May 2011
NCT00902005 Completed Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment April 2008 August 2012
NCT05839925 Completed Prevalence of Temporomandibular Joint Dysfunction in Patients With Ankylosing Spondylitis April 1, 2022 April 1, 2023
NCT00913302 Completed N/A Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis January 2008 November 2010
NCT00944658 Completed Phase 2 Spondylitis Trial of Apremilast for Better Rheumatic Therapy August 2009 January 2011
NCT00953979 Completed Phase 4 Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis January 2008 December 2009
NCT01038011 Completed Phase 2 Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study June 2004 August 2006
NCT01060098 Completed T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade April 2010 December 2012
NCT01061723 Completed Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis February 2010 June 2011
NCT01077843 Completed Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163) August 17, 2009 July 1, 2015
NCT01078558 Completed A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) May 13, 2004 January 11, 2018
NCT01079182 Completed Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS) January 2006 May 2014
NCT01081717 Completed Golimumab Safety and Surveillance Program Using the Ingenix NHI Database April 14, 2009 May 31, 2015
NCT01083121 Completed Surveillance of Humira Injection in Korean Patients April 2007 June 2012
NCT01083693 Completed Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs September 2008 June 2010
NCT01091675 Completed Phase 3 Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs September 2010 May 2013
NCT01104987 Completed Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) October 2009 July 2016
NCT01109940 Completed Phase 2 Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis April 2010 December 2012
NCT01114880 Completed Phase 3 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis January 2010 February 2011
NCT05771376 Completed N/A The Effects of Baduanjin Qigong Exercise on Ankylosing Spondylitis: A Randomized Controlled Study February 13, 2022 April 7, 2023
NCT01163916 Completed Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care January 2008 November 2011
NCT01176682 Completed Observational Study on Non-steroid Anti-inflammatory Drugs (NSAIDs) Treated Patients With Arthritic Disorder August 2010 August 2011
NCT01220518 Completed Phase 1 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) October 2010 June 2012
NCT01248793 Completed Phase 3 Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis October 2010 March 2012
NCT01273519 Completed Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab January 2011 January 2013
NCT01282372 Completed Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab March 2011 July 2014
NCT05589922 Completed The Relationship Between Abnormal Modified Schober Index and Demographic Characteristics and Clinical Variables October 24, 2022 January 30, 2023
NCT01302730 Completed Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study April 2011 November 2013
NCT01329380 Completed Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation) October 27, 2010 December 28, 2017
NCT01330901 Completed Phase 2 Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis October 2011 May 2013
NCT01351311 Completed N/A Resistance Training Exercise Using the Swiss Ball in Ankylosing Spondylitis March 2011 November 2012
NCT01357018 Completed Quality of Life in Chronic Arthritis November 2010 April 2013
NCT01358175 Completed Phase 3 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis October 2011 December 2014
NCT01361542 Completed N/A Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population February 2011 January 2012
NCT01387802 Completed Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis June 29, 2011 December 16, 2019
NCT01389388 Completed N/A Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease January 2013 August 2013
NCT05570656 Completed N/A Modeling Spinal Mobility in Ankylosing Spondylitis: Towards New Telekinetic Biomarkers December 13, 2022 September 14, 2023
NCT01417455 Completed Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis January 2012 May 2015
NCT01421303 Completed Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel. October 2009 December 2013
NCT05467995 Completed Phase 2 A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis June 2, 2021 May 19, 2022
NCT01463189 Completed Phase 2 Web-based Support to Manage Arthritis Pain September 2011 November 2012
NCT01474876 Completed Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis November 2011 May 2014
NCT01511926 Completed Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns January 2012 March 2014
NCT01517620 Completed Phase 4 Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy November 2011 November 2012
NCT01519375 Completed Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) March 2012 May 2012
NCT01571206 Completed Phase 1 An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 March 2012 May 2013
NCT01586650 Completed Phase 3 Effects of Aerobic Training in Patients With Ankylosing Spondylitis July 2011 February 2013
NCT01668004 Completed Phase 4 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) September 3, 2012 April 30, 2015
NCT01685424 Completed Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) June 30, 2006 March 1, 2015
NCT05429801 Completed N/A Ozone Therapy in Ankylosing Spondylitis December 1, 2018 December 30, 2019
NCT01690273 Completed N/A Exercise Therapy Program in Ankylosing Spondylitis Patients July 2012 November 2014
NCT04212806 Completed French Validation of Axial Spondyloarthritis Questionnaires (Val-SpA) January 27, 2020 December 31, 2020
NCT04018599 Completed Phase 1 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS July 15, 2019 March 17, 2020
NCT04209881 Completed Ovarian Reserve and Ankylosing Spondylitis December 19, 2019 May 19, 2020
NCT04156620 Completed Phase 3 Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA December 11, 2019 December 20, 2022
NCT04135508 Completed Phase 3 A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira December 13, 2016 May 31, 2018
NCT04095169 Completed Biomarkers in Early-stage Spondyloarthritis January 1, 2015 October 1, 2020
NCT00085995 Completed Progression of Spinal Fusion in Ankylosing Spondylitis December 3, 2004
NCT00126724 Completed Phase 1/Phase 2 Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects August 2005 May 2009
NCT03800797 Completed Phase 4 Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis May 25, 2015 December 10, 2015
NCT00081562 Completed Genetics of Ankylosing Spondylitis September 1999 December 2006
NCT00085644 Completed Phase 3 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis January 2004 July 2009
NCT03866135 Completed Bone Mineral Density, Disease Duration, and Activity in Ankylosing Spondylitis July 1, 2018 January 31, 2019
NCT04292028 Completed N/A The Effects of Clinical Pilates Training in Patients With Ankylosing Spondylitis June 1, 2017 June 1, 2018
NCT03926195 Completed Phase 2 Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis May 28, 2019 May 10, 2023
NCT03928743 Completed Phase 3 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis April 25, 2019 August 8, 2022
NCT04239521 Completed The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata October 1, 2020 November 28, 2022
NCT03941184 Completed Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity January 1, 1995 November 10, 2020
NCT01709656 Completed N/A A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis March 2012 December 2014
NCT01750528 Completed Prevalence and Progression of Periodontitis in Ankylosing Spondylitis September 2012 May 2014
NCT01754727 Completed Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice December 2012 October 2015
NCT01768858 Completed Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice February 5, 2013 August 13, 2017
NCT01786668 Completed Phase 2 Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis April 2013 March 2015
NCT01793285 Completed An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial December 2010 February 2012
NCT00004288 Completed Phase 2 Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis May 1996 December 1999
NCT01833468 Completed Functional Limitations Due To The Foot Involvement In Spondyloarthritis February 2013 April 2013
NCT01845818 Completed Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium June 5, 2013 June 23, 2017
NCT01850121 Completed Remicade in the Treatment of Patients With Active Ankylosing Spondylitis January 2003 May 2008
NCT05115370 Completed Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 November 1, 2021 January 14, 2022
NCT01856569 Completed Assial - Anti Tnf Treatment in Ankylosing Spondylitis: an Observational Cohort Study in Italy July 2013 November 2015
NCT01895764 Completed Phase 4 Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS) March 2013 April 2015
NCT01931644 Completed At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions July 2013 April 2024
NCT01934933 Completed Phase 4 Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis September 24, 2014 January 30, 2017
NCT00056719 Completed Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study June 19, 2003
NCT01988506 Completed Phase 2 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases January 6, 2014 April 1, 2021
NCT02019602 Completed Phase 1 A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta January 2014 November 2016
NCT05098600 Completed The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic October 15, 2021 December 20, 2022
NCT02154425 Completed Phase 1 A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers September 2014 January 2016
NCT02186873 Completed Phase 3 A Study of Golimumab in Participants With Active Ankylosing Spondylitis September 3, 2014 October 11, 2016
NCT02201043 Completed Phase 2 Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis February 2013 February 2015
NCT02202850 Completed Defining Remission With Etanercept in AS in Real Life Clinical Practice August 12, 2014 April 26, 2017
NCT05051943 Completed A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response September 29, 2020 January 20, 2023
NCT04943237 Completed Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis July 1, 2019 October 1, 2019
NCT02284646 Completed N/A Physical Training Program in Ankylosing Spondylitis November 25, 2014 November 30, 2019
NCT02311842 Completed To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS January 2012 December 2013
NCT04840485 Completed Phase 2/Phase 3 Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis June 9, 2021 February 28, 2024
NCT02333383 Completed Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients December 31, 2014 August 8, 2017
NCT02359903 Completed Phase 1 Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis February 2015 November 2015
NCT04803383 Completed N/A The Effects of Tele-Yoga in Ankylosing Spondylitis Patients April 14, 2021 May 30, 2022
NCT02466217 Completed Phenomics in Autoimmune and Inflammatory Diseases July 29, 2015 July 18, 2022
NCT04772976 Completed Relationship Between Diet, Oxidative Stress and Inflammation in Ankylosing Spondylitis November 16, 2020 February 3, 2021
NCT02492217 Completed Phase 4 Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients May 2015 May 28, 2018
NCT04749537 Completed Work Productivity and Social Activities In Patients With Ankylosing Spondylitis April 15, 2019 December 15, 2020
NCT02505542 Completed Phase 3 Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo July 2015 April 2019
NCT02525042 Completed Genetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics Approach August 2011
NCT02528201 Completed Phase 4 A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis September 2002 November 2004
NCT02538341 Completed Phase 2 Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) May 2016 December 2020
NCT00056849 Completed Genetic Determinants of Ankylosing Spondylitis Severity March 24, 2003 January 3, 2020
NCT02605642 Completed Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade September 10, 2015 December 31, 2018
NCT04746196 Completed Galectin-3 Level in Ankylosing Spondylitis Patients January 1, 2017 August 30, 2017
NCT04713813 Completed N/A Effectiveness of Hippotherapy Simulator in Ankylosing Spondylitis January 13, 2021 April 15, 2022
NCT04673825 Completed N/A Monitoring Spondyloarthritis With SpA-Net December 2, 2020 July 1, 2023
NCT04655612 Completed Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases December 1, 2020 July 30, 2021
NCT02697968 Completed N/A Electroacupuncture for Relieving Pain in Ankylosing Spondylitis March 2016 December 2017
NCT02750592 Completed Phase 3 Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis March 22, 2016 May 16, 2018
NCT02750800 Completed Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) April 7, 2016 April 3, 2018
NCT02758782 Completed Phase 4 NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis September 2016 January 2021
NCT02762812 Completed Phase 3 Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis January 2016 July 2017
NCT02763046 Completed Phase 4 Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis May 31, 2016 September 24, 2019
NCT02763111 Completed Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis September 2016 June 2017
NCT02840695 Completed Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS) January 2005 October 24, 2017
NCT02922192 Completed Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis January 1, 2012 June 1, 2020
NCT02925338 Completed National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life October 19, 2016 April 12, 2021
NCT04582084 Completed Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis April 4, 2014 March 19, 2018
NCT02963506 Completed Phase 2 A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis October 2016 August 2018
NCT03074656 Completed N/A The Norwegian Drug Monitoring Study March 1, 2017 December 14, 2020
NCT03117270 Completed Phase 2 A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis March 7, 2017 July 2, 2018
NCT03140657 Completed Phase 2 The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients April 29, 2017 January 18, 2018
NCT04507763 Completed Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis August 1, 2020 October 1, 2020
NCT03159767 Completed N/A A Clinimetric Test of Spinal Sensors in Measuring Spinal Mobility in Axial Spondyloarthritis May 24, 2017 May 2, 2018
NCT03211559 Completed N/A Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis December 20, 2017 December 20, 2018
NCT03215277 Completed Phase 2 A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis October 4, 2017 May 25, 2020
NCT03259074 Completed Phase 3 Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) November 30, 2017 November 29, 2021
NCT04507659 Completed Phase 2 Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis December 1, 2020 August 2, 2022
NCT03350815 Completed Phase 4 Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis March 13, 2018 May 29, 2021
NCT03355573 Completed Phase 2 A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis November 28, 2017 October 19, 2022
NCT03411798 Completed Phase 4 Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS December 15, 2017 July 1, 2019
NCT04481139 Completed Phase 2/Phase 3 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis October 14, 2020 May 12, 2023
NCT04451681 Completed N/A Evaluation of Physical Performance in Ankylosing Spondylitis Patients January 1, 2021 January 1, 2022
NCT04437394 Completed Evaluation of Functions of Swallowing and Voice in Ankylosing Spondylitis Patients June 30, 2018 October 30, 2018
NCT03502616 Completed Phase 3 Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) June 7, 2018 August 20, 2020
NCT04435860 Completed Muscle Strength Evaluations in Ankylosing Spondylitis June 18, 2020 September 4, 2020
NCT04402554 Completed Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis May 19, 2020 March 19, 2021
NCT04345458 Completed Phase 3 Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis March 6, 2014 July 20, 2015
NCT03667625 Completed N/A Stretching in Water and on Land for Patients With Ankylosing Spondylitis February 2016 September 6, 2016
NCT04320459 Completed Alexithymia in Ankylosing Spondylitis February 1, 2016 August 15, 2016
NCT04301128 Completed N/A The Effect of Mobile Application on Anti-TNF Drug Adherence of Ankylosing Spondylitis Patients: Pilot Study December 27, 2017 December 31, 2019
NCT03761212 Completed Function, Locomotion, Measurement and Inflammation August 13, 2018 February 10, 2022
NCT05792358 Enrolling by invitation N/A Wet Cupping Therapy in Ankylosing Spondylitis February 1, 2023 December 1, 2024
NCT05257174 Enrolling by invitation N/A The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis June 15, 2022 June 2024
NCT01789151 No longer available 99m-Technetium- Glucosamine in Arthritis
NCT06198985 Not yet recruiting N/A The Effect of Dynamic Balance Exercises on Balance in Patients With Ankylosing Spondylitis. January 1, 2024 July 1, 2025
NCT05962762 Not yet recruiting Phase 1 Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis August 30, 2023 December 31, 2027
NCT06242652 Not yet recruiting Phase 2 A Study to Evaluate 608 in Patients With Ankylosing Spondylitis (AS) March 19, 2024 June 15, 2025
NCT05703932 Not yet recruiting N/A Effect of Exercise on Disease Activity in Patients With Ankylosing Spondylitis by SIRI and SII February 1, 2023 April 15, 2024
NCT05164198 Not yet recruiting Phase 4 REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST) January 15, 2022 October 31, 2024
NCT05760105 Not yet recruiting Awareness of Osteoporosis in Ankylosing Spondylosis Patients December 1, 2023 December 1, 2024
NCT06460805 Recruiting N/A axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis April 25, 2024 August 1, 2025
NCT01797224 Recruiting OTIS Autoimmune Diseases in Pregnancy Project March 2012 October 2026
NCT01965132 Recruiting Korean College of Rheumatology Biologics and Targeted Therapy Registry December 1, 2012 June 30, 2030
NCT02557308 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis August 2014 June 2026
NCT03839862 Recruiting Faecal Analyses in Spondyloarthritis Therapy January 1, 2019 December 31, 2026
NCT03840928 Recruiting PatientSpot Formerly Known as ArthritisPower April 1, 2015 March 1, 2025
NCT04402086 Recruiting Rheumatology Patient Registry and Biorepository August 4, 2020 June 1, 2030
NCT04751396 Recruiting Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors April 20, 2022 April 15, 2025
NCT04924270 Recruiting Phase 2 Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases December 13, 2023 December 31, 2026
NCT05096767 Recruiting Neuropathic Spinal Pain Descriptors in Ankylosing Spondylitis October 15, 2021 September 2024
NCT05450133 Recruiting Hematological Parameters in Axial Spondyloarthritis July 15, 2022 February 15, 2024
NCT05598684 Recruiting SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases November 24, 2022 December 30, 2025
NCT05603728 Recruiting Exactech Shoulder Post Market Clinical Follow-up Study January 2010 September 30, 2031
NCT05609643 Recruiting Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan July 6, 2022 December 31, 2025
NCT05635266 Recruiting Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives October 26, 2021 October 2025
NCT05715463 Recruiting N/A Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity March 1, 2023 April 1, 2027
NCT05835518 Recruiting An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS January 26, 2023 August 2026
NCT05861102 Recruiting Phase 3 Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS) July 20, 2023 July 2025
NCT05861128 Recruiting Phase 3 Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS) November 10, 2023 December 2025
NCT05866614 Recruiting A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps January 13, 2023 March 2027
NCT05883371 Recruiting IMPACT - AndHealth Autoimmune Research Registry June 8, 2023 May 22, 2028
NCT05913817 Recruiting The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications. January 9, 2023 November 13, 2024
NCT05968469 Recruiting N/A The Effects of Aerobic Exercise in Patients With Ankylosing Spondylitis July 30, 2023 October 30, 2024
NCT05997108 Recruiting Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis August 1, 2023 February 1, 2024
NCT05999643 Recruiting N/A Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT July 1, 2023 August 1, 2025
NCT06000956 Recruiting Phase 3 A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo September 15, 2023 August 15, 2026
NCT06076083 Recruiting Multi-omics Database for Integrative Microbiome Analysis in a Cohort of Korean Patients With Ankylosing Spondylitis October 6, 2023 December 31, 2027
NCT06250062 Recruiting Phase 2 A Clinical Study of JS005 in Patients With Ankylosing Spondylitis January 12, 2024 October 8, 2025
NCT06287983 Recruiting N/A Effect of Inspiratory Muscle Training on Respiratory Functions and Exercise Capacity June 1, 2023 May 15, 2024
NCT06339957 Recruiting Rheumatology Diet Study March 1, 2024 July 1, 2024
NCT06369324 Recruiting N/A Efficacy of Pain Neuroscience Education and Physiotherapy in Patients Diagnosed With Spondyloarthritis February 15, 2024 April 11, 2024
NCT06378697 Recruiting Phase 3 A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis November 10, 2023 April 30, 2026
NCT06392620 Recruiting N/A Telerehabilitation in Ankylosing Spondylitis April 20, 2024 July 20, 2024
NCT06451588 Recruiting Phase 2 Fecal Microbiota Transplantation in Axial Spondyloarthritis June 1, 2024 March 2026
NCT04281238 Suspended N/A The Effects of Yoga Training in Ankylosing Spondylitis Patients October 26, 2020 December 2021
NCT00273858 Terminated Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis March 2006 July 2010
NCT01694264 Terminated Phase 3 Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα September 1, 2012 December 31, 2015
NCT04839315 Terminated Early Phase 1 COVID-19 Vaccination in Rheumatic Disease Patients February 15, 2021 February 9, 2022
NCT03473665 Terminated Phase 4 Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis March 1, 2018 August 2, 2019
NCT00811499 Terminated Phase 2 A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis December 16, 2008 September 29, 2009
NCT02685904 Terminated Phase 3 A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis September 6, 2016 December 31, 2018
NCT02328027 Terminated Phase 1/Phase 2 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS) December 11, 2014 October 17, 2017
NCT01118728 Terminated Phase 2 Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis June 2010 December 2011
NCT01422564 Terminated Phase 4 Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem January 2007 December 2010
NCT00910273 Terminated Phase 4 Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients July 2009 October 2011
NCT04125147 Terminated N/A Clinical Investigation of MONTAGE in Adults With Spinal Deformity Undergoing Pedicle Subtraction Osteotomy December 5, 2019 July 20, 2023
NCT03329885 Terminated Phase 1/Phase 2 A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis November 2, 2017 June 26, 2018
NCT01411215 Terminated A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department January 2011 January 2013
NCT04795141 Terminated Phase 2 ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis August 24, 2021 August 30, 2022
NCT04077164 Terminated Chronic Pain, Couples, & Physical Activity April 9, 2019 December 30, 2020
NCT02260284 Unknown status N/A The Effect of Acupuncture in Treating Chronic Low-back Pain October 2014 October 2019
NCT00517101 Unknown status Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy September 2007
NCT02132234 Unknown status Phase 4 Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis June 2013
NCT01852851 Unknown status N/A Employment and Arthritis: Making it Work June 2013 June 2023
NCT01790022 Unknown status Phase 2 Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL) July 2012
NCT05190484 Unknown status bIosimilar of aDalimumab, an European evAluation April 30, 2022 April 30, 2024
NCT05379049 Unknown status Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis. March 1, 2022 October 1, 2022
NCT01685905 Unknown status The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection April 2012 September 2013
NCT00432653 Unknown status Phase 2/Phase 3 Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis March 2007 November 2009
NCT01420432 Unknown status Phase 1 Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS) January 2011 December 2013
NCT01289743 Unknown status Phase 2 Etanercept (Enbrel) in Ankylosing Spondylitis February 2002 May 2012
NCT00747578 Unknown status Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan September 2008
NCT00244166 Unknown status Phase 2/Phase 3 Prednisolone in Active Ankylosing Spondylitis (AS) May 2002 August 2008
NCT00558506 Unknown status Phase 2 Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis January 2008 December 2009
NCT01286545 Unknown status European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study February 2011 October 2013
NCT00243750 Unknown status Phase 2 Methotrexate in Ankylosing Spondylitis (MTX in AS) September 2003 November 2005
NCT01167413 Unknown status Frequency of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia August 2010 January 2011
NCT00237419 Unknown status N/A Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis December 2005 April 2011
NCT04089774 Unknown status N/A Benefit of Adapted Physical Activity for Patients Suffering From Ankylosing Spondylitis May 14, 2019 June 14, 2022
NCT04077957 Unknown status Phase 4 Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs October 7, 2019 July 2, 2022
NCT03152396 Unknown status N/A Pharmacist CVD Intervention for Patients With Inflammatory Arthritis July 17, 2017 September 2018
NCT02687620 Unknown status Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study September 2014 April 2021
NCT02666313 Unknown status N/A WEB-Based Physiotherapy for People With Axial Spondyloarthritis November 2015 October 2017
NCT02638896 Unknown status Phase 4 Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis January 2016 April 2017
NCT02503891 Unknown status N/A AL-2 MP-1 (Polyimide) Acetabular Liner September 15, 2017 August 2020
NCT00224562 Unknown status The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists February 2004
NCT02489760 Unknown status Phase 4 Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study July 2008 October 2016
NCT02456363 Unknown status Phase 2 Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis November 2009 December 2019
NCT04820725 Unknown status N/A The Effects of Postural Changes on Plantar Pressure in Patients With Ankylosing Spondylitis October 31, 2021 December 2, 2022
NCT02313727 Unknown status Phase 4 Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression December 2014 September 2017
NCT04867148 Unknown status N/A The Prediction and Prevention of Disease by Using Big Data in Motion Analysis September 1, 2019 December 31, 2022
NCT04875299 Unknown status Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients September 2021 May 2023
NCT04885751 Unknown status Phase 4 Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy June 1, 2021 January 31, 2022
NCT04934059 Unknown status Phase 4 Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS). July 1, 2021 January 31, 2022
NCT02260310 Unknown status N/A The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis October 2014 January 2018
NCT05038189 Unknown status N/A Evaluation of Spine Posture, Trunk Position Sense and Gait in Axial Spondyloarthritis Patients July 15, 2021 March 2022
NCT03557853 Unknown status Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab June 2016 September 2020
NCT03470688 Unknown status Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents March 1, 2018 December 31, 2021
NCT03457285 Unknown status N/A Investigating the Use of Salaso to Improve Physiotherapy Management of Ankylosing Spondylitis (AS). October 17, 2018 May 31, 2019
NCT04480359 Unknown status Phase 2/Phase 3 Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis October 1, 2017 September 30, 2020
NCT03452735 Unknown status Fertility Study of Women With Chronic Inflammatory Rheumatism July 16, 2018 July 2019
NCT02962479 Unknown status Is the Human Microbiome Altered in Patients With Axial Spondyloarthritis? October 2016 October 2017
NCT03932006 Unknown status Phase 4 A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis June 30, 2016 May 31, 2019
NCT03904953 Unknown status N/A Effects of Pilates Training on Respiratory Muscle Strenght in Patients With Ankylosing Spondylitis April 2, 2019 October 2, 2019
NCT03729674 Unknown status Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs November 26, 2018 December 31, 2022
NCT03726645 Unknown status Early Phase 1 The Effect of Fecal Microbiota Transplantation in Ankylosing Spondylitis (AS) Patients. October 24, 2018 April 2020
NCT03639740 Unknown status Phase 4 Treat-to-target With Secukinumab in Axial Spondyloarthritis January 15, 2019 February 2021
NCT04386538 Unknown status N/A Effect of a Low Starch Diet in Patients With Ankylosing Spondylitis January 3, 2022 December 30, 2022
NCT04400786 Unknown status N/A A Randomized Open-labeled Study for Comparing Methods of Using Imrecoxib to Treat AS May 7, 2020 June 30, 2022
NCT00235105 Unknown status Phase 2/Phase 3 D2E7-Early AS March 2005 June 2007
NCT03636984 Unknown status Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World August 24, 2018 December 24, 2020
NCT04411485 Unknown status Sexual Dysfunction in Partner of Patients With Ankylosing Spondylitis February 15, 2018 July 15, 2020
NCT04424589 Unknown status N/A Efficacy of Myofascial Release in Patients With Axial Spondyloarthritis. December 2020 June 2021
NCT04426747 Unknown status Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis September 1, 2019 October 30, 2020
NCT03937271 Withdrawn Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome April 1, 2019 December 31, 2020
NCT04483700 Withdrawn Phase 3 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy December 2020 June 2024
NCT01148901 Withdrawn Phase 4 Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) June 2010 December 2010
NCT01692457 Withdrawn A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis July 2013 July 2016
NCT05119712 Withdrawn Early Phase 1 Terbinafine Treatment of Axial Spondyloarthropathy March 9, 2021 October 15, 2024
NCT04483687 Withdrawn Phase 3 Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy December 2020 September 2024
Disase is a (Disease Ontology)
DOID:3342
Cross Reference ID (Disease Ontology)
EFO:0003898
Cross Reference ID (Disease Ontology)
GARD:9518
Cross Reference ID (Disease Ontology)
ICD10CM:M45
Cross Reference ID (Disease Ontology)
ICD9CM:720.0
Cross Reference ID (Disease Ontology)
MESH:D013167
Cross Reference ID (Disease Ontology)
MIM:PS106300
Cross Reference ID (Disease Ontology)
NCI:C84564
Cross Reference ID (Disease Ontology)
ORDO:825
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:156619005
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0038013
Exact Synonym (Disease Ontology)
Bekhterev syndrome
Exact Synonym (Disease Ontology)
Bekhterev's disease
Exact Synonym (Disease Ontology)
Marie-Strumpell disease
ICD10 preferred id (Insert disease from ICD10)
D0010522
ICD10 class code (Insert disease from ICD10)
M45